The Combination of Single-Cell and Next-Generation Sequencing Can Reveal Mosaicism for BRCA2 Mutations and the Fine Molecular Details of Tumorigenesis

SIMPLE SUMMARY: Germline and somatic BRCA1/2 mutations may define therapeutic targets and refine cancer treatment options. However, routine BRCA diagnostic approaches cannot reveal the exact time and origin of BRCA1/2 mutation formation, and thus, the fine details of their contribution to tumor prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Gráf, Alexandra, Enyedi, Márton Zsolt, Pintér, Lajos, Kriston-Pál, Éva, Jaksa, Gábor, Bálind, Árpád, Ezer, Éva, Horváth, Péter, Sükösd, Farkas, Kiss, Ernő, Haracska, Lajos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153129/
https://www.ncbi.nlm.nih.gov/pubmed/34068254
http://dx.doi.org/10.3390/cancers13102354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153129/
https://www.ncbi.nlm.nih.gov/pubmed/34068254
http://dx.doi.org/10.3390/cancers13102354

Ejemplares similares